KSB-51287-18703
4 vaccinations
10 coded responses
32 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-23
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Anxious because people have reported symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: Swelling · Headache, Muscle or body achesFree text: Sore under armpit of arm that got injectedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral — Feeling: Good · Site: SwellingFree text: Swelling under arm that was injected and armpit swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral — Feeling: Good · Site: SwellingFree text: Swelling under arm and armpit of injected armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Oedema peripheral — Feeling: Good · Site: SwellingFree text: Swelling in under arm and arm pit of vaccinated armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-19
-
2021-04-22
Survey response — day 7, dose 2MedDRA: Oedema peripheral, Pain in extremity — Feeling: GoodFree text: Swelling and slight pain under infected armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-07-13
- 2021-10-12
-
2021-12-13
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-04-13
-
2022-06-13
Survey response — 6 months, dose 3MedDRA: Malaise, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID symptoms returned after having recoveredMedDRA releases: 2024-11 · check-in free text available
-
2022-06-13
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-14
-
2022-12-01
Dose 4 — Pfizer-BioNTech
- 2022-12-16
-
2022-12-16
Survey response — 12 months, dose 3MedDRA: COVID-19, Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I got recurring upper respiratory issues in May ( after April COVID) and again in July and then again in September. All after long plane rides.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-20
- 2022-12-20
- 2022-12-22
-
2022-12-23
Call successfulNot applicable - Accidental Reporting
-
2022-12-23
Call successfulCompleted over the phone
- 2022-12-29
- 2023-01-09
- 2023-01-14
-
2023-03-02
Survey response — 3 months, dose 4MedDRA: Malaise — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-02
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-03
-
2023-03-03
Call successfulCompleted over the phone
-
2023-06-01
Survey response — 6 months, dose 4MedDRA: Arthralgia, Magnetic resonance imaging abnormal, Office visit, Spinal osteoarthritis, Spinal pain — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-06-01
Call case (no matching report) — SuccessfulReported to VAERS during previous contact from GDIT
-
2023-06-02
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Pfizer-BioNTech | Flu |
| 4 | 2022-12-01 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 3
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Anxious because people have reported symptoms
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Sore under armpit of arm that got injected
Systemic reaction (other): Swelling under arm that was injected and armpit swelling
Systemic reaction (other): Swelling under arm and armpit of injected arm
Systemic reaction (other): Swelling in under arm and arm pit of vaccinated arm
Release 7 — day 7, dose 2
Systemic reaction (other): Swelling and slight pain under infected arm
Release 12 — 6 months, dose 3
Symptoms: COVID symptoms returned after having recovered
Release 12 — 12 months, dose 3
Symptoms: I got recurring upper respiratory issues in May ( after April COVID) and again in July and then again in September. All after long plane rides.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Magnetic resonance imaging abnormal | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Spinal osteoarthritis | · | · | ✓ |
| SD | Spinal pain | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release